Yes. A dose-dependent decrease in triglycerides, HMG-CoA reductase, and cholesterol was observed afer treatment with Olivetol. Olivetol was able to inhibit the storage of excess fat in the liver caused by obesity (steatohepatitis) by lowering the levels of liver enzymes. Based on the results of the biochemical tests and experimental data, it can be concluded that Olivetol has a benefcial impact on obesity. However, further research is required to determine the individual and/or synergistic efects of this compound.